News
(2)April 2026
Tempest Therapeutics, Inc. — 424B3 Filing
# 🧾 What This Document Is This is a prospectus filing with the SEC. Its main job is to let certain investors ("selling stockholders") legally resell up to **2,777,781 shares** of Tempest Therapeutics' common stock to the public. Think of it as a "resale permit" for these specific shares. 👉 **The
Tempest Therapeutics, Inc. — 424B3 Filing
# 🔥 What This Document Is This is a **prospectus**, a legal document that registers shares for resale. Tempest Therapeutics (ticker: TPST) is filing this so a group of "selling stockholders" can sell up to **8,268,495 shares** of its common stock on the open market. These shares weren't just printe
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.